Literature DB >> 9928501

Enthesiopathy: clinical manifestations, imaging and treatment.

I Olivieri1, L Barozzi, A Padula.   

Abstract

Enthesitis is a distinctive pathological feature of spondyloarthropathy and may involve synovial joints, cartilaginous joints, syndesmoses and extra-articular entheses. This review focuses on peripheral extra-articular enthesitis which is a clinical hallmark of spondyloarthropathy. The entheses of the lower limbs are more frequently involved than those of the upper limbs, and heel enthesitis is the most frequent. Entheseal pain may be mild or moderate as well as severe and disabling. Peripheral enthesitis may be observed in all forms of spondyloarthropathy, including the undifferentiated ones, and may for a long time be the only long-standing clinical manifestation of the B27-associated disease process. Various imaging methods have been suggested for studying peripheral enthesitis. Ultrasonography and magnetic resonance imaging are the most useful because they may show alterations of the structures involved. Therapy of peripheral enthesitis consists of NSAIDs, orthoses and physical therapy. Steroid injections, second line drugs such as sulphasalazine and radiotherapy are reserved for more severe cases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9928501     DOI: 10.1016/s0950-3579(98)80043-5

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  20 in total

1.  Lateral epicondylitis with marked soft tissue swelling in spondyloarthritis.

Authors:  Ignazio Olivieri; Enrico Scarano; Giovanni Ciancio; Vincenzo Giasi; Angela Padula
Journal:  Clin Rheumatol       Date:  2004-04-08       Impact factor: 2.980

2.  Ultrasound revealing subclinical enthesopathy at the greater trochanter level in patients with spondyloarthritis.

Authors:  Marwin Gutierrez; Filippo Luccioli; Fausto Salaffi; Elena Bartoloni; Chiara Bertolazzi; Vittorio Bini; Emilio Filipucci; Walter Grassi; Roberto Gerli
Journal:  Clin Rheumatol       Date:  2011-10-21       Impact factor: 2.980

3.  An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment.

Authors:  Fabio Massimo Perrotta; Davide Astorri; Marcello Zappia; Alfonso Reginelli; Luca Brunese; Ennio Lubrano
Journal:  Rheumatol Int       Date:  2016-09-06       Impact factor: 2.631

4.  Construct validity and sensitivity to change of Belgrade Ultrasound Enthesitis Score in patients with spondyloarthritis: a pilot study.

Authors:  Sanja Milutinovic; Goran Radunovic; Kristina Veljkovic; Maja Zlatanovic; Nemanja Damjanov
Journal:  Rheumatol Int       Date:  2017-12-13       Impact factor: 2.631

Review 5.  Management issues with elderly-onset rheumatoid arthritis: an update.

Authors:  Ignazio Olivieri; Carlo Palazzi; Giovanni Peruz; Angela Padula
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

6.  Ultrasound detection of entheseal insertions in the foot of patients with spondyloarthropathy.

Authors:  Pinar Borman; Suha Koparal; Seçil Babaoğlu; Hatice Bodur
Journal:  Clin Rheumatol       Date:  2005-11-01       Impact factor: 2.980

Review 7.  Imaging of the seronegative spondyloarthropathies.

Authors:  A A Luong; D C Salonen
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

8.  Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy.

Authors:  P V Balint; D Kane; H Wilson; I B McInnes; R D Sturrock
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

9.  A morphological adaptation? The prevalence of enlarged external occipital protuberance in young adults.

Authors:  David Shahar; Mark G L Sayers
Journal:  J Anat       Date:  2016-03-22       Impact factor: 2.610

Review 10.  MRI of enthesitis of the appendicular skeleton in spondyloarthritis.

Authors:  Iris Eshed; Matthias Bollow; Dennis G McGonagle; Ai Lyn Tan; Christian E Althoff; Patrick Asbach; Kay-Geert A Hermann
Journal:  Ann Rheum Dis       Date:  2007-05-25       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.